GABRIELLE BASILE: Open Payments
NPI 1003405697 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,338 in 59 payments from 14 companies in 2025. Trend: 2023 $297 · 2024 $1,029 · 2025 $1,338
Food & beverage: $1,338
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $312 |
| Incyte Corporation | 12 | $204 |
| UCB, Inc. | 5 | $156 |
| Arcutis Biotherapeutics, Inc. | 9 | $153 |
| Janssen Biotech, Inc. | 3 | $102 |
| Novartis Pharmaceuticals Corporation | 3 | $100 |
| Regeneron Healthcare Solutions, Inc. | 4 | $95 |
| GENZYME CORPORATION | 1 | $36 |
| PFIZER INC. | 1 | $35 |
| Organon LLC | 2 | $34 |
Products named: SKYRIZI, OPZELURA, Bimzelx, Zoryve, DUPIXENT, TREMFYA, Rhapsido, CIBINQO.
Industry payments across NY — which companies pay providers there.
